1889-836X

1889-836X

S1889-836X2021000200003

10.4321/s1889-836x2021000200003

España

España

España

España

España

00 06 2021

00 06 2021

13 2 58 65

1

2014 25 5 5

1439-43

2

2019 393 10169 10169

364-76

3

1993 101 13 13

481-3

4

2009 20 3 3

393-8

5

2013 78 5 5

681-6

6

2014 77 3 3

282-6

7

2017 32 8 8

1599-606

8

2019 126

2-10

9

2014 29 1 1

223-33

10

2004 48 3 3

141-5

11

1988 48

837-41

12

2005 16 12 12

2013-7

13

2004 80 5 5

142-6

14

2010 65 9 9

591-6

15

2016 27 1 1

319-30

16

2017 101

70-6

17

2005 205 3 3

277-85

18

1993 22 4 4

684-91

19

2014 68

41-5

20

2015 36 5 5

216-20

21

2019 19 1 1

1-7

22

2001 119 2 2

48-53

23

2017 130 1 1

171-80

24

2019 9 1 1

1-13

25

2005 8 4 4

430-5

26

2012 91 2 2

114-20

27

2002 13 6 6

487-92

28

1998 4

385-93

29

World Medical Association

2013 310 20 20

2013-6

30

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy

2001 285 6 6

785-95

31

2020 15 1 1

1-7

32

2017 32 4 4

676-80

33

2020 31 3 3

413-27

34

2019 13 2 2

161-7

35

2005 76 1 1

2-13

36

2017 28 2 2

495-503

37

2011 26 12 12

2843-50

38

1992 51 3 3

169-72

39

2010 95 4 4

1767-76

40

1996 11 8 8

1052-60

41

2021 4 1 1

42

2013 9 4 4

703-8

43

2020 132 17-18 17-18

547-8